ARTICLE | Clinical News
MoxDuoIR: Phase II/III started
February 23, 2009 8:00 AM UTC
QRxPharma began an open-label, U.S. Phase II/III trial to compare oral MoxDuoIR vs. morphine and Percocet oxycodone/acetaminophen in 45 patients undergoing total knee replacement surgery. ...